Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000108
Filing Date
2025-01-02
Accepted
2025-01-02 16:36:38
Documents
2
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form3-01022025_090135.html 3  
1 form3-01022025_090135.xml 3 6506
2 ex24-01022025_090136.htm EX-24 5274
  Complete submission text file 0001415889-25-000108.txt   13174
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SILENCE THERAPEUTICS PLC 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address
Ede-Golightly James (Reporting) CIK: 0002048873 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39487 | Film No.: 25502560